I knew I forgot one. That is part of the national pharmaceutical strategy discussion. The paper has a number of elements in it, including catastrophic drugs. It also talks about ways to contain costs better. Are there ways we can collaborate better to ensure that there's access to drugs at an affordable cost to the system? I don't believe you could talk about one without the other. Doing one helps pay for the other. That's the kind of discussion we're going to have at the health ministers' meeting in two weeks' time.
